Renal Cancer
Showing NaN - NaN of 5
Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)
Active, not recruiting
- Melanoma
- +7 more
- Autogene cevumeran
- Atezolizumab
-
Scottsdale, Arizona
- +36 more
Dec 22, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Ovarian Cancer, Renal Cancer, NSCLC Trial in United States (Carfilzomib, Dexamethasone)
Completed
- Ovarian Cancer
- +6 more
-
Scottsdale, Arizona
- +6 more
Jul 14, 2017
Renal Cancer, Kidney Cancer Trial in United States (Bevacizumab)
Completed
- Renal Cancer
- Kidney Cancer
-
Fort Myers, Florida
- +12 more
Dec 12, 2014